{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:53:53Z","timestamp":1771667633126,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00380-018-1319-x","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T16:12:45Z","timestamp":1544026365000},"page":"916-925","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Impact of decreased insulin resistance by ezetimibe on postprandial lipid profiles and endothelial functions in obese, non-diabetic-metabolic syndrome patients with coronary artery disease"],"prefix":"10.1007","volume":"34","author":[{"given":"Akihiro","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenjiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masateru","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Nozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,5]]},"reference":[{"key":"1319_CR1","doi-asserted-by":"publisher","first-page":"322","DOI":"10.5551\/jat.11.322","volume":"11","author":"A Tanaka","year":"2004","unstructured":"Tanaka A (2004) Postprandial hyperlipidemia and atherosclerosis. J Atheroscler Thromb 11:322\u2013329","journal-title":"J Atheroscler Thromb"},{"key":"1319_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.metabol.2017.07.002","volume":"75","author":"E S\u00f8ndergaard","year":"2017","unstructured":"S\u00f8ndergaard E, Johansen RF, Jensen MD, Nielsen S (2017) Postprandial VLDL-TG metabolism in type 2 diabetes. Metabolism 75:25\u201335","journal-title":"Metabolism"},{"key":"1319_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.5551\/jat.RV16003","volume":"24","author":"D Masuda","year":"2017","unstructured":"Masuda D, Yamashita S (2017) Postprandial hyperlipidemia and remnant lipoproteins. J Atheroscler Thromb 24:95\u2013109","journal-title":"J Atheroscler Thromb"},{"key":"1319_CR4","doi-asserted-by":"publisher","first-page":"E891","DOI":"10.1152\/ajpendo.00287.2016","volume":"311","author":"IY Kim","year":"2016","unstructured":"Kim IY, Park S, Chou TH, Trombold JR, Coyle EF (2016) Prolonged sitting negatively affects the postprandial plasma triglyceride-lowering effect of acute exercise. Am J Physiol Endocrinol Metab 311:E891\u2013E898","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1319_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/204748730000700504","volume":"7","author":"HM Roche","year":"2000","unstructured":"Roche HM, Gibney MJ (2000) The impact of postprandial lipemia in accelerating atherothrombosis. J Cardiovasc Risk 7:317\u2013324","journal-title":"J Cardiovasc Risk"},{"key":"1319_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/aje\/153.5.490","volume":"153","author":"H Iso","year":"2001","unstructured":"Iso H, Naito Y, Sato S, Kitamura A, Okamura T, Sankai T, Shimamoto T, Iida M, Komachi Y (2001) Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol 153:490\u2013499","journal-title":"Am J Epidemiol"},{"key":"1319_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jjcc.2015.12.001","volume":"67","author":"K Nakamura","year":"2016","unstructured":"Nakamura K, Miyoshi T, Yunoki K, Ito H (2016) Postprandial hyperlipidemia as a potential residual risk factor. J Cardiol 67:335\u2013339","journal-title":"J Cardiol"},{"key":"1319_CR8","doi-asserted-by":"publisher","first-page":"31646","DOI":"10.1074\/jbc.M200544200","volume":"277","author":"M Haidari","year":"2002","unstructured":"Haidari M, Leung N, Mahbub F, Uffelman KD, Kohen-Avramoglu R, Lewis GF, Adeli K (2002) Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J Biol Chem 277:31646\u201331655","journal-title":"J Biol Chem"},{"key":"1319_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jjcc.2012.07.010","volume":"60","author":"S Hiramitsu","year":"2012","unstructured":"Hiramitsu S, Miyagishima K, Ishii J, Mstsui S, Naruse H, Shiino K, Kitagawa F, Ozaki Y (2012) The effect of ezetimibe on lipid and glucose metabolism after a fat and glucose load. J Cardiol 60:395\u2013400","journal-title":"J Cardiol"},{"key":"1319_CR10","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640\u20131645","journal-title":"Circulation"},{"key":"1319_CR11","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1161\/STROKEAHA.106.479642","volume":"38","author":"T Ninomiya","year":"2007","unstructured":"Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Rahman M, Arima H, Tsuryuya K, Iida M, Kiyohara Y (2007) Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study. Stroke 38:2063\u20132069","journal-title":"Stroke"},{"key":"1319_CR12","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1253\/circj.CJ-09-0264","volume":"73","author":"A Higashiyama","year":"2009","unstructured":"Higashiyama A, Okumura T, Ono Y, Watanabe M, Kokubo Y, Okayama A (2009) Risk of smoking and metabolic syndrome for incidence urban Japanese population: the Suita study. Circ J 73:2258\u20132263","journal-title":"Circ J"},{"key":"1319_CR13","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1126\/science.1093131","volume":"303","author":"SW Altman","year":"2004","unstructured":"Altman SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Telzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Graziano MP (2004) Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science 303:1201\u20131204","journal-title":"Science"},{"key":"1319_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1046\/j.1365-2125.2002.01633.x","volume":"54","author":"T Kosoglou","year":"2002","unstructured":"Kosoglou T, Meyer I, Veltri EP, Statkevich P, Yang B, Zhu Y, Mellars L, Maxwell SE, Patrick JE, Cutler DL, Batra VK, Affrime MB (2002) Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin. Br J Clin Pharmacol 54:309\u2013319","journal-title":"Br J Clin Pharmacol"},{"key":"1319_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.atherosclerosis.2011.04.019","volume":"217","author":"K Yunoki","year":"2011","unstructured":"Yunoki K, Nakamura K, Miyoshi T, Enko K, Kohno K, Morita H, Kusano KF, Ito H (2011) Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction. Atherosclerosis 217:486\u2013491","journal-title":"Atherosclerosis"},{"key":"1319_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijcme.2013.10.001","volume":"1","author":"N Kumagai","year":"2013","unstructured":"Kumagai N, Miura S, Zhang B, Noda K, Saku K, Investigators Zenith Trial (2013) Effects of ezetimibe on hypercholesterolemia in the lipid profile in patients with metabolic syndrome: Zenith trial. IJC Metab Endcr 1:7\u201312","journal-title":"IJC Metab Endcr"},{"key":"1319_CR17","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"37","author":"GM Reaven","year":"1988","unstructured":"Reaven GM (1988) Banting lecture 1988: role of insulin resistance in human disease. Diabetes 37:1595\u20131607","journal-title":"Diabetes"},{"key":"1319_CR18","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1253\/circj.CJ-12-0125","volume":"76","author":"JE Yun","year":"2012","unstructured":"Yun JE, Won S, Sung J, Jee SH (2012) Impact of metabolic syndrome independent of insulin resistance on the development of cardiovascular disease. Circ J 76:2443\u20132448","journal-title":"Circ J"},{"key":"1319_CR19","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.1016\/j.febslet.2007.11.023","volume":"581","author":"M Deushi","year":"2007","unstructured":"Deushi M, Nomura M, Kawakami A, Haraguchi M, Ito M, Okazaki M, Ishii H, Yoshida M (2007) Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. FEBS Lett 581:5664\u20135670","journal-title":"FEBS Lett"},{"key":"1319_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-511X-14-1","volume":"14","author":"H Adachi","year":"2015","unstructured":"Adachi H, Nakano H, Yamamoto K, Nakata M, Bekki H, Honma T, Yoshiyama H, Nohara M, ERASE METS Study Investigators (2015) Ezetimibe ameliorates atherogenic lipids profiles, insulin resistance and hepatocyte growth factor in obese patients with hypercholesterolemia. Lipids Health Dis 14:1","journal-title":"Lipids Health Dis"},{"key":"1319_CR21","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1007\/s00380-015-0757-y","volume":"31","author":"A Nakamura","year":"2016","unstructured":"Nakamura A, Monma Y, Kajitani S, Noda K, Nakajima S, Endo H, Takahashi T, Nozaki E (2016) Effect of glycemic state on postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery disease. Heart Vessels 31:1446\u20131455","journal-title":"Heart Vessels"},{"key":"1319_CR22","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/0140-6736(92)93147-F","volume":"340","author":"DS Celermajer","year":"1992","unstructured":"Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111\u20131115","journal-title":"Lancet"},{"key":"1319_CR23","first-page":"188","volume":"94","author":"Y Matsuzawa","year":"2005","unstructured":"Matsuzawa Y (2005) Metabolic syndrome: definition and diagnosis criteria in Japan. J Jpn Soc Intern Med 94:188\u2013203","journal-title":"J Jpn Soc Intern Med"},{"key":"1319_CR24","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc10-S011","volume":"33","author":"American Diabetes Association","year":"2010","unstructured":"American Diabetes Association (2010) Standards of medical care in diabetes\u20142010. Diabetes Care 33:S11\u2013S61","journal-title":"Diabetes Care"},{"key":"1319_CR25","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"SD Fihn","year":"2012","unstructured":"Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB 3rd, Kligfield PD, Krumholz HM, Kwong RY, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR Jr, Smith SC Jr, Spertus JA, Williams SV (2012) 2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 60:e44\u2013e164","journal-title":"J Am Coll Cardiol"},{"key":"1319_CR26","doi-asserted-by":"publisher","first-page":"E1264","DOI":"10.1152\/ajpendo.00320.2012","volume":"303","author":"AS Cornford","year":"2012","unstructured":"Cornford AS, Barkan AL, Hinko A, Horowitz JF (2012) Suppression in growth hormone during overeating ameliorates the increase in insulin resistance and cardiovascular disease risk. Am J Physiol Endocrinol Metab 303:E1264\u2013E1272","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1319_CR27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"1319_CR28","first-page":"257","volume":"39","author":"Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R; International Brachial Artery Reactivity Task Force","year":"2002","unstructured":"Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R; International Brachial Artery Reactivity Task Force (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257\u2013265","journal-title":"J Am Coll Cardiol"},{"key":"1319_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/FJC.0b013e31817ffe76","volume":"52","author":"JK Olijhoek","year":"2008","unstructured":"Olijhoek JK, Hajer GR, van der Graaf Y, Dallinga-Thie GM, Visseren FL (2008) The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial. J Cardiovasc Pharmacol 52:145\u2013150","journal-title":"J Cardiovasc Pharmacol"},{"key":"1319_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.atherosclerosis.2008.04.035","volume":"202","author":"GR Hajer","year":"2009","unstructured":"Hajer GR, Dallinga-Thie GM, Visseren FLJ (2009) The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients. Atherosclerosis 202:216\u2013224","journal-title":"Atherosclerosis"},{"key":"1319_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00535-010-0291-8","volume":"46","author":"H Park","year":"2011","unstructured":"Park H, Shima T, Yamaguchi K, Mitsuyoshi H, Minami M, Yasui K, Itoh Y, Yoshikawa T, Fukui M, Hasegawa G, Nakamura N, Ohta M, Obayashi H, Okanoue T (2011) Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. J Gastroenterol 46:101\u2013107","journal-title":"J Gastroenterol"},{"key":"1319_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/jdi.12298","volume":"6","author":"K Ohbu-Murayama","year":"2015","unstructured":"Ohbu-Murayama K, Adachi H, Hirai Y, Enomoto M, Fukami A, Obuchi A, Yoshimura A, Nakamura S, Nohara Y, Nakao E, Umeki Y, Fukumoto Y (2015) Ezetimibe combined with standard diet and exercise therapy improves insulin resistance and atherosclerotic markers in patients with metabolic syndrome. J Diabetes Invest 6:325\u2013333","journal-title":"J Diabetes Invest"},{"key":"1319_CR33","doi-asserted-by":"publisher","first-page":"914","DOI":"10.5551\/jat.4929","volume":"17","author":"JC Sandoval","year":"2010","unstructured":"Sandoval JC, Nakagawa-Toyama Y, Masuda D, Tochino Y, Nakaoka H, Kawase R, Yuasa-Kawase M, Nakatani K, Inagaki M, Tsubakio-Yamamoto K, Ohama T, Matsuyama A, Nishida M, Ishigami M, Komuro I, Yamashita S (2010) Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia. J Atheroscler Thromb 17:914\u2013924","journal-title":"J Atheroscler Thromb"},{"key":"1319_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/01.mol.0000162322.39548.b1","volume":"16","author":"RM Fisher","year":"2005","unstructured":"Fisher RM, Gertow K (2005) Fatty acid transport proteins and insulin resistance. Curr Opin Lipidol 16:173\u2013178","journal-title":"Curr Opin Lipidol"},{"key":"1319_CR35","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.tem.2013.04.001","volume":"24","author":"ME Haas","year":"2013","unstructured":"Haas ME, Attie AD, Biddinger SB (2013) The regulation of ApoB metabolism by insulin. Trends Endocrinol Metab 24:391\u2013397","journal-title":"Trends Endocrinol Metab"},{"key":"1319_CR36","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"37","author":"GM Reaven","year":"1988","unstructured":"Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595\u20131607","journal-title":"Diabetes"},{"key":"1319_CR37","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.117.030950","volume":"137","author":"RP Giugliano","year":"2018","unstructured":"Giugliano RP, Cannon CP, Blazing MA, Nicolau JC, Corbal\u00e1n R, \u0160pinar J, Park JG, White JA, Bohula EA, Braunwald E, IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators (2018) Benefit of adding ezetimibe to statin therapy on cardiovascular outcomes and safety in patients with versus without diabetes mellitus: results from IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation 137:1571\u20131582","journal-title":"Circulation"},{"key":"1319_CR38","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.2174\/13816128113199990314","volume":"19","author":"N Katsiki","year":"2013","unstructured":"Katsiki N, Theocharidou E, Karagiannis A, Athyros VG, Mikhailidis DP (2013) Ezetimibe therapy for dyslipidemia: an update. Curr Pharm Des 19:3107\u20133114","journal-title":"Curr Pharm Des"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-018-1319-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-018-1319-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-018-1319-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:36:24Z","timestamp":1575506184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-018-1319-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,5]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1319"],"URL":"https:\/\/doi.org\/10.1007\/s00380-018-1319-x","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,5]]},"assertion":[{"value":"19 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}